Skip to main content
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1996 Jun;72(3):217–219. doi: 10.1136/sti.72.3.217

Emergency hormonal contraception usage in genitourinary medicine clinic attenders.

J K Evans 1, A Holmes 1, M Browning 1, G E Forster 1
PMCID: PMC1195655  PMID: 8707328

Abstract

OBJECTIVE: To assess the indications for usage of emergency hormonal contraception amongst a population of London genitourinary medicine clinic attenders. METHODS: In a prospective study, 150 consecutive women receiving emergency hormonal contraception (EHC) were enrolled. The attending doctor completed a questionnaire of patient details and prescribed EHC with prophylactic prochlorperazine. Follow-up was arranged three weeks later, at which time outcomes and side-effects of therapy were recorded. For those women who did not reattended as planned case notes were reviewed at three months. RESULTS: Of 150 women surveyed, 100 (66%) reported contraceptive method failure, 48 (32%) had used no contraception at the time of last sexual intercourse and two requested EHC after sexual assault. Ninety three (62%) reported condom failure, 7 (5%) oral contraceptive pill failure. Seventy five (50%) had used EHC before (range 1-10 times). Seventy one (47%) women reattended within three months. Five (3.3%) of the 150 women were pregnant; none of these cases had experienced nausea or vomiting whilst taking EHC. Side-effects were reported by 22 (31%) of the 71 patients who reattended. Nine (6%) women had been followed-up in the family planning advisory clinic. Of the 71 women who reattended, 39 (55%) reported that their preferred future method of contraception would be condoms. Of the 150 women 19 (13%) underwent tests for sexually transmissible infections within one month of presentation. CONCLUSIONS: EHC usage in this population was associated with a failure rate of at least 3.3% and an overall side effect rate of 31%. Despite requests for emergency contraception because of condom failure many elected to continue using condoms as their preferred method of contraception. The majority of women (53%) did not return for follow-up or family planning advice, and so we believe that future contraceptive plans must be addressed at the time EHC is prescribed.

Full text

PDF
217

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagshaw S. N., Edwards D., Tucker A. K. Ethinyl oestradiol and D-norgestrel is an effective emergency postcoital contraceptive: a report of its use in 1,200 patients in a family planning clinic. Aust N Z J Obstet Gynaecol. 1988 May;28(2):137–140. doi: 10.1111/j.1479-828x.1988.tb01643.x. [DOI] [PubMed] [Google Scholar]
  2. Bromham D. R., Cartmill R. S. Knowledge and use of secondary contraception among patients requesting termination of pregnancy. BMJ. 1993 Feb 27;306(6877):556–557. doi: 10.1136/bmj.306.6877.556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. George J., Turner J., Cooke E., Hennessy E., Savage W., Julian P., Cochrane R. Women's knowledge of emergency contraception. Br J Gen Pract. 1994 Oct;44(387):451–454. [PMC free article] [PubMed] [Google Scholar]
  4. Masters L., Nicholas H., Bunting P., Welch J. Family planning in genitourinary medicine: an opportunistic service? Genitourin Med. 1995 Apr;71(2):103–105. doi: 10.1136/sti.71.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Smith R. P., Ross A. Post-coital contraception using d1-norgestrel/ethinyl estradiol combination. Contraception. 1978 Mar;17(3):247–252. doi: 10.1016/0010-7824(78)90016-1. [DOI] [PubMed] [Google Scholar]
  6. Yuzpe A. A., Smith R. P., Rademaker A. W. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent. Fertil Steril. 1982 Apr;37(4):508–513. doi: 10.1016/s0015-0282(16)46157-1. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES